Navigation Links
NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis
Date:12/2/2008

immunization.

About the National Foundation for Infectious Diseases

The National Foundation for Infectious Diseases (NFID) is a non-profit, tax-exempt 501(c)(3) organization founded in 1973 and dedicated to educating the public and healthcare professionals about the causes, treatment and prevention of infectious diseases.

NFID's S.T.O.P. Meningitis! (Share. Teach. Outreach. Protect.) coalition is dedicated to providing health care providers with in-practice resources to implement the CDC's meningococcal immunization recommendations and educate patients about meningococcal disease and vaccination. NFID's S.T.O.P. Meningitis! initiative is made possible by an unrestricted educational grant to NFID from sanofi pasteur.


'/>"/>
SOURCE National Foundation for Infectious Diseases
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. HAP Expands Medicare Advantage Options to Include Acupuncture and Chiropractic Services
2. PharmMD Expands Advisory Board
3. CVCTA Education Expands to Six New Campuses and Finalizes Acquisition Of CVI Training
4. World-Renowned Urologist, J. Francois Eid, M.D., Expands Practice with Increased Treatment of Benign Prostate Hyperplasia (BPH)
5. Environmental and Technology Firm Integral Consulting Inc. Expands Services, Launches New Website
6. PaperThin Experiences Record Growth : Grows Revenues, Expands Channel, and Maintains 95%+ Subscription Renewal Rate
7. The SCOOTER Store Expands Power Mobility Products, Services to 7 Million Health Plan Members
8. Anpath Group, Inc. Expands International Distribution With Minntech Corporation
9. Baxa Expands its Automated Syringe Processing Capabilities
10. Crazy Water Expands Distribution to Whole Foods Market(R)
11. Millennium Pharmacy Systems Expands into West Virginia
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Baxa Corporation Releases IntelliFlowRx 28TM 29 Upgrades 49198 1Baxa Corporation Releases IntelliFlowRx 28TM 29 Upgrades 49198 2Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 1Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 2Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 3Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 4Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 5Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 6Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 7Stroke Damage Is Less in Rats Given Opioids 49194 1